Summary

Persistence Market Research has recently released a comprehensive report on the global Point of Care Lipid Test Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

• Point of Care Lipid Test Market Size (2025E): US$ 734.5 Million
• Projected Market Value (2032F): US$ 1,195.0 Million
• Global Market Growth Rate (CAGR 2025 to 2032): 7.2%

Point of Care Lipid Test Market - Report Scope:

The point of care lipid test market comprises diagnostic instruments and consumables designed to provide rapid lipid profile analysis at or near the site of patient care. These tests are widely used for the detection and monitoring of lipid and lipoprotein disorders, atherosclerosis, diabetes mellitus, liver and renal diseases, and other cardiovascular risk factors. The increasing prevalence of cardiovascular diseases, growing emphasis on preventive healthcare, and rising demand for quick diagnostic solutions are driving market expansion. Technological advancements in portable testing devices and the growing adoption of decentralized healthcare models are further supporting market growth.

Market Growth Drivers:

The global point of care lipid test market is witnessing significant growth due to the rising burden of cardiovascular diseases and metabolic disorders worldwide. Increasing awareness regarding the importance of early diagnosis and routine lipid monitoring is encouraging the adoption of point-of-care testing solutions. The growing prevalence of diabetes, obesity, and hypercholesterolemia has further increased the demand for rapid lipid screening. Additionally, advancements in diagnostic technologies have led to the development of accurate, portable, and user-friendly testing devices, enabling healthcare providers to deliver faster clinical decisions and improved patient outcomes.

Market Restraints:

Despite favorable growth prospects, the point of care lipid test market faces several challenges. The high cost of advanced testing instruments and consumables can limit adoption in cost-sensitive healthcare settings. Concerns regarding test accuracy and variability compared to centralized laboratory testing may also hinder market penetration. Furthermore, stringent regulatory requirements for diagnostic device approvals and limited reimbursement policies in certain regions can create barriers for market expansion. Lack of awareness and inadequate healthcare infrastructure in developing economies may further restrain market growth.

Market Opportunities:

The point of care lipid test market presents substantial opportunities owing to the increasing focus on personalized medicine and preventive healthcare strategies. Expanding healthcare access in emerging economies and growing investments in decentralized diagnostic solutions are expected to create new growth avenues. Technological innovations such as wireless connectivity, digital health integration, and AI-enabled diagnostic platforms can further enhance the efficiency and adoption of point-of-care lipid testing. Moreover, rising demand for home-based healthcare services and remote patient monitoring is anticipated to generate significant opportunities for manufacturers operating in this market.

Key Questions Answered in the Report:

• What are the primary factors driving the global point of care lipid test market's growth?
• Which regions and market segments are experiencing the highest demand for point of care lipid testing solutions?
• How are technological advancements influencing market dynamics?
• Who are the key players in the point of care lipid test market, and what strategies are they adopting to stay competitive?
• What are the emerging trends and future projections for the global point of care lipid test market?

Competitive Intelligence and Business Strategy:

Leading companies in the global point of care lipid test market are focusing on product innovation, strategic collaborations, and expansion of distribution networks to strengthen their market presence. Manufacturers are investing heavily in research and development activities to improve testing accuracy, reduce turnaround time, and enhance device portability. Partnerships with healthcare providers, diagnostic laboratories, and research institutions are helping companies broaden their customer base and accelerate product adoption. Furthermore, increasing emphasis on digital healthcare integration and remote monitoring capabilities is enabling market players to gain a competitive advantage in the evolving diagnostic landscape.

Companies Covered in This Report:

• Callegari Sri
• Sinocare Inc.
• Abbott Laboratories
• MiCoBio
• Nova Biomedical Corporation
• VivaChek Biotech (Hangzhou) Co., Ltd.
• F. Hoffmann-La Roche Ltd.
• Menarini Group
• SD Biosensor, Inc.

Market Segmentation

By Product Type

• Instruments
• Consumables

By Disease Indication

• Lipid and Lipoprotein Disorders
• Atherosclerosis
• Liver and Renal Diseases
• Diabetes Mellitus
• Others

By Application

• Hyperlipidemia
• Hypertriglyceridemia
• Tangier Disease
• Hyperlipoproteinemia
• Familial Hypercholesterolemia
• Others

By Region

• North America
• Europe
• East Asia
• South Asia & Oceania
• Latin America
• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Point of Care Lipid Test Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. COVID-19 Impact Analysis
2.4. Forecast Factors - Relevance and Impact
3. Value Chain Analysis
3.1. Supply Chain Analysis
3.2. List of Key Market Players
4. Value Added Insights
4.1. PESTLE Analysis
4.2. Porter’s Five Force Analysis
5. Price Trend Analysis, 2019 - 2032
5.1. Pricing Analysis, By Product Type
5.2. Key Factors Impacting Prices, Disease Indication
6. Global Point of Care Lipid Test Market Outlook
6.1. Key Highlights
6.1.1. Market Size (US$ Mn) and Y-o-Y Growth
6.1.2. Absolute $ Opportunity
6.2. Market Size (US$ Mn) Analysis and Forecast
6.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
6.2.2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
6.3. Global Point of Care Lipid Test Market Outlook: Product Type
6.3.1. Historical Market Size (US$ Mn) Analysis, By Product Type, 2019-2024
6.3.2. Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
6.3.2.1. Instruments
6.3.2.2. Consumables
6.3.3. Market Attractiveness Analysis: Product Type
6.4. Global Point of Care Lipid Test Market Outlook: Disease Indication
6.4.1. Historical Market Size (US$ Mn) Analysis, By Disease Indication, 2019-2024
6.4.2. Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025-2032
6.4.2.1. Lipid and Lipoprotein Disorders
6.4.2.2. Atherosclerosis
6.4.2.3. Liver and Renal Diseases
6.4.2.4. Diabetes Mellitus
6.4.2.5. Others
6.4.3. Market Attractiveness Analysis: Disease Indication
6.5. Global Point of Care Lipid Test Market Outlook: Application
6.5.1. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2024
6.5.2. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
6.5.2.1. Hyperlipidemia
6.5.2.2. Hypertriglyceridemia
6.5.2.3. Tangier Disease
6.5.2.4. Hyperlipoproteinemia
6.5.2.5. Familial Hypercholesterolemia
6.5.2.6. Others
6.5.3. Market Attractiveness Analysis: Application
7. Global Point of Care Lipid Test Market Outlook: Region
7.1. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
7.2. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
7.2.1. North America
7.2.2. Europe
7.2.3. East Asia
7.2.4. South Asia and Oceania
7.2.5. Latin America
7.2.6. Middle East & Africa
7.3. Market Attractiveness Analysis: Region
8. North America Point of Care Lipid Test Market Outlook
8.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
8.1.1. By Country
8.1.2. By Product Type
8.1.3. By Disease Indication
8.1.4. By Application
8.2. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
8.2.1. U.S.
8.2.2. Canada
8.3. Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
8.3.1. Instruments
8.3.2. Consumables
8.4. Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025-2032
8.4.1. Lipid and Lipoprotein Disorders
8.4.2. Atherosclerosis
8.4.3. Liver and Renal Diseases
8.4.4. Diabetes Mellitus
8.4.5. Others
8.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
8.5.1. Hyperlipidemia
8.5.2. Hypertriglyceridemia
8.5.3. Tangier Disease
8.5.4. Hyperlipoproteinemia
8.5.5. Familial Hypercholesterolemia
8.5.6. Others
8.6. Market Attractiveness Analysis
9. Europe Point of Care Lipid Test Market Outlook
9.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
9.1.1. By Country
9.1.2. By Product Type
9.1.3. By Disease Indication
9.1.4. By Application
9.2. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
9.2.1. Germany
9.2.2. France
9.2.3. U.K.
9.2.4. Italy
9.2.5. Spain
9.2.6. Russia
9.2.7. Türkiye
9.2.8. Rest of Europe
9.3. Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
9.3.1. Instruments
9.3.2. Consumables
9.4. Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025-2032
9.4.1. Lipid and Lipoprotein Disorders
9.4.2. Atherosclerosis
9.4.3. Liver and Renal Diseases
9.4.4. Diabetes Mellitus
9.4.5. Others
9.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
9.5.1. Hyperlipidemia
9.5.2. Hypertriglyceridemia
9.5.3. Tangier Disease
9.5.4. Hyperlipoproteinemia
9.5.5. Familial Hypercholesterolemia
9.5.6. Others
9.6. Market Attractiveness Analysis
10. East Asia Point of Care Lipid Test Market Outlook
10.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
10.1.1. By Country
10.1.2. By Product Type
10.1.3. By Disease Indication
10.1.4. By Application
10.2. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.3. Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
10.3.1. Instruments
10.3.2. Consumables
10.4. Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025-2032
10.4.1. Lipid and Lipoprotein Disorders
10.4.2. Atherosclerosis
10.4.3. Liver and Renal Diseases
10.4.4. Diabetes Mellitus
10.4.5. Others
10.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
10.5.1. Hyperlipidemia
10.5.2. Hypertriglyceridemia
10.5.3. Tangier Disease
10.5.4. Hyperlipoproteinemia
10.5.5. Familial Hypercholesterolemia
10.5.6. Others
10.6. Market Attractiveness Analysis
11. South Asia & Oceania Point of Care Lipid Test Market Outlook
11.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
11.1.1. By Country
11.1.2. By Product Type
11.1.3. By Disease Indication
11.1.4. By Application
11.2. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
11.2.1. India
11.2.2. Southeast Asia
11.2.3. ANZ
11.2.4. Rest of South Asia & Oceania
11.3. Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
11.3.1. Instruments
11.3.2. Consumables
11.4. Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025-2032
11.4.1. Lipid and Lipoprotein Disorders
11.4.2. Atherosclerosis
11.4.3. Liver and Renal Diseases
11.4.4. Diabetes Mellitus
11.4.5. Others
11.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
11.5.1. Hyperlipidemia
11.5.2. Hypertriglyceridemia
11.5.3. Tangier Disease
11.5.4. Hyperlipoproteinemia
11.5.5. Familial Hypercholesterolemia
11.5.6. Others
11.6. Market Attractiveness Analysis
12. Latin America Point of Care Lipid Test Market Outlook
12.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
12.1.1. By Country
12.1.2. By Product Type
12.1.3. By Disease Indication
12.1.4. By Application
12.2. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
12.2.1. Brazil
12.2.2. Mexico
12.2.3. Rest of Latin America
12.3. Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
12.3.1. Instruments
12.3.2. Consumables
12.4. Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025-2032
12.4.1. Lipid and Lipoprotein Disorders
12.4.2. Atherosclerosis
12.4.3. Liver and Renal Diseases
12.4.4. Diabetes Mellitus
12.4.5. Others
12.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
12.5.1. Hyperlipidemia
12.5.2. Hypertriglyceridemia
12.5.3. Tangier Disease
12.5.4. Hyperlipoproteinemia
12.5.5. Familial Hypercholesterolemia
12.5.6. Others
12.6. Market Attractiveness Analysis
13. Middle East & Africa Point of Care Lipid Test Market Outlook
13.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
13.1.1. By Country
13.1.2. By Product Type
13.1.3. By Disease Indication
13.1.4. By Application
13.2. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
13.2.1. GCC Countries
13.2.2. Egypt
13.2.3. South Africa
13.2.4. Northern Africa
13.2.5. Rest of Middle East & Africa
13.3. Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
13.3.1. Instruments
13.3.2. Consumables
13.4. Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025-2032
13.4.1. Lipid and Lipoprotein Disorders
13.4.2. Atherosclerosis
13.4.3. Liver and Renal Diseases
13.4.4. Diabetes Mellitus
13.4.5. Others
13.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
13.5.1. Hyperlipidemia
13.5.2. Hypertriglyceridemia
13.5.3. Tangier Disease
13.5.4. Hyperlipoproteinemia
13.5.5. Familial Hypercholesterolemia
13.5.6. Others
13.6. Market Attractiveness Analysis
14. Competition Landscape
14.1. Market Share Analysis, 2025
14.2. Market Structure
14.2.1. Competition Intensity Mapping By Market
14.2.2. Competition Dashboard
14.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
14.3.1. Callegari Sri
14.3.1.1. Overview
14.3.1.2. Segments and Product Type
14.3.1.3. Key Financials
14.3.1.4. Market Developments
14.3.1.5. Market Strategy
14.3.2. Sinocare Inc.
14.3.3. Abbott Laboratories
14.3.4. MiCoBio
14.3.5. Nova Biomedical Corporation
14.3.6. VivaChek Biotech (Hangzhou) Co., Ltd.
14.3.7. F. Hoffmann-La Roche Ltd.
14.3.8. Menarini Group
14.3.9. SD Biosensor, Inc.
15. Appendix
15.1. Research Methodology
15.2. Research Assumptions
15.3. Acronyms and Abbreviations